56 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2214594/vertex-pharmaceuticals-vrtx-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2214594
Jan 23, 2024 - Vertex Pharmaceuticals (VRTX) reachead $439.70 at the closing of the latest trading day, reflecting a -0.09% change compared to its last close.
zc:-4995843641822017375
0
https://www.zacks.com/stock/news/2215148/pbyi-or-vrtx-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2215148
Jan 24, 2024 - PBYI vs. VRTX: Which Stock Is the Better Value Option?
zc:-2350510544640088412
0
https://www.zacks.com/stock/news/2217975/exelixis-exel-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2217975
Jan 30, 2024 - Exelixis (EXEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-5002820532536192630
0
https://www.zacks.com/stock/news/2256422/vertex-pharmaceuticals-vrtx-stock-falls-amid-market-uptick-what-investors-need-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2256422
Apr 16, 2024 - Vertex Pharmaceuticals (VRTX) closed at $394.17 in the latest trading session, marking a -0.8% move from the prior day.
zc:4673453729111682178
0
https://www.zacks.com/stock/news/2258650/vertex-vrtx-begins-rolling-nda-filing-for-acute-pain-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2258650
Apr 19, 2024 - Vertex (VRTX) begins rolling NDA submission for its investigational non-opioid candidate, suzetrigine, for acute pain management. The submission is expected to be completed in second-quarter 2024.
zc:5119310641520788903
0
https://www.zacks.com/stock/news/2262685/biotech-stock-roundup-biib-bmy-s-q1-earnings-incy-s-acquisition-updates-from-vrtx?cid=CS-ZC-FT-analyst_blog|earnings_article-2262685
Apr 25, 2024 - Biogen (BIIB) and Bristol Myers (BMY) are in focus following Q1 earnings announcement.
zc:8506602132430980156
0